List of doctors and approaches - Revision history

User123: /* HBOT (Hyperbaric oxygen therapy) */ charite group

2026-06-10T10:13:51Z

HBOT (Hyperbaric oxygen therapy): charite group

← Older revision		Revision as of 10:13, 10 June 2026
Line 26:		Line 26:

	'''How to get more information''': The study results paper can be found at [https://doi.org/10.1038/s41598-022-15565-0 DOI:10.1038/s41598-022-15565-0]. The researchers have published additional analyses on [https://doi.org/10.1016/j.nicl.2022.103218 functional and structural connectivity] and [https://doi.org/10.1038/s41598-023-36570-x myocardial function].		'''How to get more information''': The study results paper can be found at [https://doi.org/10.1038/s41598-022-15565-0 DOI:10.1038/s41598-022-15565-0]. The researchers have published additional analyses on [https://doi.org/10.1016/j.nicl.2022.103218 functional and structural connectivity] and [https://doi.org/10.1038/s41598-023-36570-x myocardial function].

			'''Charité group case study''': This group studied HBOT on ME/CFS patients. https://doi.org/10.1101/2025.10.29.25339096 @mecfsskeptic on Twitter [https://x.com/mecfsskeptic/status/1984906452419453143 notes]: "there was no control group, and the improvements were far from impressive."

	===Antihistamines===		===Antihistamines===

User123: /* Statin and maraviroc effectiveness */

2026-05-17T02:28:34Z

Statin and maraviroc effectiveness

← Older revision		Revision as of 02:28, 17 May 2026
Line 349:		Line 349:

	The Patterson group study had a retrospective observational design and would be less reliable than a RCT (randomized controlled trial). The lengthy survey process used in the Patterson group study may heavily bias the results because maraviroc+statin non-responders may not necessarily spend time on the phone completing lengthy questionnaires, especially if they have cognitive difficulties from long haul. The paper does not describe the drop-out rate. It also does not fully describe how 18 patients were selected out of the thousands of patients that have done an IncellDX panel test.		The Patterson group study had a retrospective observational design and would be less reliable than a RCT (randomized controlled trial). The lengthy survey process used in the Patterson group study may heavily bias the results because maraviroc+statin non-responders may not necessarily spend time on the phone completing lengthy questionnaires, especially if they have cognitive difficulties from long haul. The paper does not describe the drop-out rate. It also does not fully describe how 18 patients were selected out of the thousands of patients that have done an IncellDX panel test.

			There is an ongoing RCT for maraviroc + atorvastatin (NCT06974084).

	=== Statin plus angiotensin II type 1 receptor blockers (ARBs) ===		=== Statin plus angiotensin II type 1 receptor blockers (ARBs) ===

User123: /* Microtesla Magnetic Therapy */ s4me thread

2026-04-08T20:33:07Z

Microtesla Magnetic Therapy: s4me thread

← Older revision		Revision as of 20:33, 8 April 2026
Line 769:		Line 769:

	https://www.medrxiv.org/content/10.64898/2026.03.18.26348530v1		https://www.medrxiv.org/content/10.64898/2026.03.18.26348530v1

			Science 4 ME has [https://www.s4me.info/threads/microtesla-magnetic-therapy-for-cognitive-impairment-in-post-acute-sequelae-of-sars-cov-2-a-randomized-controlled-feasibility-study-canori-putrino.49477/ a discussion thread] critical of the published paper.
			<blockquote>In my view, if a study describes itself as exploratory and does not do multiple test correction, then what it is saying is that no efficacy conclusions can be drawn from the data, where instead the results are meant to be used as a reference for seeing if the most significant findings replicate in a followup study.

			<br />Thus, I think the conclusion makes it sound too much like they found an intervention that works:</blockquote>

	=== Whole body hypothermia ===		=== Whole body hypothermia ===

User123: Reverted edits by 109.70.100.1 (talk) to last revision by User123

2026-04-06T22:30:39Z

Reverted edits by 109.70.100.1 (talk) to last revision by User123

← Older revision		Revision as of 22:30, 6 April 2026
Line 1:		Line 1:
	Hello I have news that Dr. Jianyi Yan's clinic at Flushing has been rigged with C4 bombs by Iranian agents. They say that even if the bombs fail to explode for any reasons, Erika Herzog's home and herself and her family will get targeted. That's all because of her Zionist activism and her support of the attacks against Iran.

	~~yours truly,~~
	~~hazysummersky~~

	== !!! Important note and disclaimer !!! ==		== !!! Important note and disclaimer !!! ==

109.70.100.1 at 09:32, 4 April 2026

2026-04-04T09:32:28Z

← Older revision		Revision as of 09:32, 4 April 2026
Line 1:		Line 1:
			Hello I have news that Dr. Jianyi Yan's clinic at Flushing has been rigged with C4 bombs by Iranian agents. They say that even if the bombs fail to explode for any reasons, Erika Herzog's home and herself and her family will get targeted. That's all because of her Zionist activism and her support of the attacks against Iran.

			yours truly,
			hazysummersky

	== !!! Important note and disclaimer !!! ==		== !!! Important note and disclaimer !!! ==

User123: /* Fluvoxamine */

2026-04-01T13:11:12Z

Fluvoxamine

← Older revision		Revision as of 13:11, 1 April 2026
Line 94:		Line 94:

	https://www.acpjournals.org/doi/10.7326/ANNALS-25-03959		https://www.acpjournals.org/doi/10.7326/ANNALS-25-03959

			One issue is that the improvement is so small that it may not be [https://x.com/SpichakSimon/status/2038778656097444144 clinically meaningful].

	Some of the keys author (e.g. Reis, Edward Mills) have faced criticism over their methodology in an unrelated RCT (the TOGETHER trial).		Some of the keys author (e.g. Reis, Edward Mills) have faced criticism over their methodology in an unrelated RCT (the TOGETHER trial).

User123: /* Fluvoxamine */

2026-04-01T00:34:37Z

Fluvoxamine

← Older revision		Revision as of 00:34, 1 April 2026
Line 95:		Line 95:
	https://www.acpjournals.org/doi/10.7326/ANNALS-25-03959		https://www.acpjournals.org/doi/10.7326/ANNALS-25-03959

	Some of the keys author (e.g. Reis, Edward Mills) have faced criticism over their methodology in an unrelated RCT (the TOGETHER trial). https://www.cato.org/regulation/summer-2022/ivermectin-together-trial https://c19early.org/togetherivm.html		Some of the keys author (e.g. Reis, Edward Mills) have faced criticism over their methodology in an unrelated RCT (the TOGETHER trial).
			* https://www.cato.org/regulation/summer-2022/ivermectin-together-trial
			* https://c19early.org/togetherivm.html
			* https://longhaulwiki.com/resources/assets/Numerous%20issues%20with%20the%20TOGETHER%20trial.pdf

	== Approaches that failed randomized controlled trials==		== Approaches that failed randomized controlled trials==

User123: /* Symptom-titrated exercise program */ fluvoxamine

2026-04-01T00:32:42Z

Symptom-titrated exercise program: fluvoxamine

← Older revision		Revision as of 00:32, 1 April 2026
Line 88:		Line 88:

	The dropout rate in this study was high. The dropout rate was higher in the intervention group than the control group, with 2 dropping out due to "worsening of fatigue". Despite this, the authors claim that the invention is safe: "The present study shows that an individualized and symptom-titrated exercise program is '''safe''' and feasible in people with PCC '''without worsening the fatigue severity'''."		The dropout rate in this study was high. The dropout rate was higher in the intervention group than the control group, with 2 dropping out due to "worsening of fatigue". Despite this, the authors claim that the invention is safe: "The present study shows that an individualized and symptom-titrated exercise program is '''safe''' and feasible in people with PCC '''without worsening the fatigue severity'''."

			=== Fluvoxamine ===

			A Brazilian study by Reis and colleagues studied the effect of fluvoxamine (and metformin) on Long COVID patients according to the Fatigue Severity Scale. "Fluvoxamine showed a significant reduction in fatigue compared with placebo at day 60 (mean difference, −0.43 [95% credible interval {CrI}, −0.80 to −0.07]), with a sustained effect at day 90 (mean difference, −0.58 [CrI, −0.98 to −0.16]). Fluvoxamine also improved quality-of-life scores with high posterior probability. "

			https://www.acpjournals.org/doi/10.7326/ANNALS-25-03959

			Some of the keys author (e.g. Reis, Edward Mills) have faced criticism over their methodology in an unrelated RCT (the TOGETHER trial). https://www.cato.org/regulation/summer-2022/ivermectin-together-trial https://c19early.org/togetherivm.html

	== Approaches that failed randomized controlled trials==		== Approaches that failed randomized controlled trials==

User123: /* Metformin and Ursodeoxycholic Acid */

2026-04-01T00:25:49Z

Metformin and Ursodeoxycholic Acid

← Older revision		Revision as of 00:25, 1 April 2026
Line 124:		Line 124:

	[https://www.acpjournals.org/doi/10.7326/ANNALS-25-04883 Published paper by Lim and colleagues]		[https://www.acpjournals.org/doi/10.7326/ANNALS-25-04883 Published paper by Lim and colleagues]

			==== Brazilian study ====
			A different study by Reis and colleagues tested the effect of metformin and fluvoxamine on Long COVID patients according to the Fatigue Severity Scale. "Metformin showed no significant benefit. Adverse events were less frequent with fluvoxamine (20.0%) than with metformin (28.8%) or placebo (29.7%). Grade 3 and higher adverse events were rare across all groups."

			https://www.acpjournals.org/doi/10.7326/ANNALS-25-03959

	=== Pycnogenol ===		=== Pycnogenol ===

User123: ivabradine moved because its RCT was completed

2026-03-30T18:04:54Z

ivabradine moved because its RCT was completed

@@ Line 154: / Line 154: @@
 https://classic.clinicaltrials.gov/ct2/show/NCT05877508
 === IVIG for POTS ===
@@ Line 340: / Line 348: @@
 The patient support organization ''The Mast Cell Disease Society'' has a list of medical centers treating MCAS at https://tmsforacure.org/resources/finding-a-physician/
 ===HELP Apheresis===